The Indian startup ecosystem, often celebrated for its software and direct-to-consumer innovations, is increasingly seeing its robust manufacturing backbone come into the limelight. Today, Swara Baby Products, a key player in the disposable hygiene sector and a subsidiary of Brainbees Solutions (the parent company of FirstCry), has formally announced its intent to go public, filing its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI). This move signals a significant maturation for a company that has quietly built a formidable presence as India’s largest contract manufacturer of disposable hygiene products. The proposed Initial Public Offering (IPO) aims to raise up to Rs 1,000 crore, a substantial sum poised to fuel an ambitious expansion strategy in a market brimming with potential.

This IPO isn’t merely a capital raise, it’s a powerful validation of Swara Baby Products’ business model and its critical role in supporting numerous consumer brands. It reflects investor confidence in the underlying strength of India’s manufacturing capabilities, particularly within a high-growth, essential consumer segment. For Brainbees Solutions, the partial exit through an Offer for Sale (OFS) also underscores a strategic move to unlock value from its successful portfolio companies, a testament to its venture-building prowess.

About Swara Baby Products: The Unsung Hero of Hygiene Manufacturing

Founded in 2016, Swara Baby Products has carved out a unique niche in the burgeoning disposable hygiene market. The company specializes in manufacturing a comprehensive range of products including baby diapers, adult diapers, sanitary napkins, disposable underpads, and wet wipes. While many consumers might recognize the brands that grace retail shelves, Swara Baby Products operates largely behind the scenes, serving as a critical contract manufacturer for a multitude of domestic and international consumer brands. Beyond its contract manufacturing services, it also markets products under its own proprietary brands, demonstrating a hybrid approach to market penetration.

Swara Baby Products has not just grown, it has dominated its segment. By fiscal year 2025, it had established itself as India’s largest contract manufacturer of disposable hygiene products by value, a remarkable achievement in a competitive landscape. This leadership position is a direct result of its unwavering focus on quality, efficiency, and scale, catering to diverse needs across baby care, feminine hygiene, and adult incontinence segments. The company’s financial trajectory further illustrates its robust performance, with operating revenue climbing 23.4% year-on-year to Rs 1,164 crore for the fiscal year ended March 2026, up from Rs 943 crore in FY25. Profitability also saw a healthy increase, growing 18.5% to Rs 96 crore during the same period. These figures paint a picture of a company with strong fundamentals and a clear growth trajectory.

A strategic move last December (December 2025) further solidified its market position when Brainbees Solutions, through Swara Baby Products, acquired a 100% stake in KA Hygiene in a share swap deal valued at Rs 57.74 crore. This acquisition not only expanded its operational footprint but also demonstrated a proactive approach to inorganic growth, further consolidating its leadership in the sector.

The IPO Deal: A Dual Strategy for Growth and Value Unlocking

The proposed IPO aims to raise a total of Rs 1,000 crore, structured into two key components. The first is a fresh issue of equity shares worth up to Rs 500 crore, representing new capital flowing directly into the company’s balance sheet. This fresh capital is earmarked for strategic growth initiatives, signaling a clear intent to expand operations and capabilities.

The second component is an Offer for Sale (OFS) of up to Rs 500 crore by existing shareholders. This allows early investors and promoter entities to monetize a portion of their stake, a natural progression for successful ventures. Brainbees Solutions Ltd, the parent company of FirstCry, which held a significant 76.59% stake in Swara Baby Products at the time of the DRHP filing, plans to sell shares worth Rs 300 crore. This partial exit is a strategic move for Brainbees Solutions, enabling it to realize substantial returns on its investment while still retaining a significant stake in Swara Baby Products’ future growth. Additionally, promoter entity Anadya Bon Merchari LLP will offer shares worth Rs 200 crore as part of the OFS.

While an IPO doesn’t involve traditional venture capital ‘investors’ in the round, the book-running lead managers play a crucial role in bringing the company to the public market. For this issue, JM Financial and Avendus Capital have been appointed as the book-running lead managers, with MUFG Intime India Private Limited serving as the registrar. Their involvement signifies their confidence in the company’s financials, growth story, and the market appetite for a robust manufacturing play. The company has also indicated the possibility of a pre-IPO placement of up to Rs 100 crore, a common strategy to gauge investor interest and potentially reduce the fresh issue size.

Deployment of Funds: Building Capacity and Fortifying the Balance Sheet

The fresh issue component of the IPO, amounting to Rs 500 crore, is meticulously allocated to accelerate Swara Baby Products’ strategic objectives. The company’s planned deployment of these funds speaks volumes about its focus on sustainable, long-term growth and operational efficiency:

  • New Manufacturing Facility: A substantial Rs 198.2 crore is earmarked for setting up a new manufacturing facility in Madhya Pradesh. This investment is critical for expanding production capacity, meeting surging demand, and potentially diversifying its product portfolio. Increasing manufacturing footprint in a strategically located state like Madhya Pradesh will enhance supply chain efficiencies and reduce logistics costs, ultimately boosting profitability.
  • Debt Repayment: Rs 100 crore will be utilized to repay certain borrowings. This move is designed to strengthen the company’s balance sheet, reduce interest expenses, and improve its financial flexibility. A healthier balance sheet often translates to better credit ratings and improved attractiveness for future capital raises or operational expansions.
  • Subsidiary Debt Repayment: An additional Rs 27.5 crore will be infused into its subsidiaries, Solis Hygiene, Swara Hygiene, and KAEHPL, specifically for the repayment of their existing debt. This centralized approach to debt management across the group ensures financial stability and operational synergy among its entities.
  • Inorganic Growth and General Corporate Purposes: The remaining proceeds will be allocated towards inorganic growth opportunities, primarily through strategic acquisitions. This indicates the company’s intent to continue its consolidation efforts, similar to its recent acquisition of KA Hygiene, to further expand market share and capabilities. A portion will also be reserved for general corporate purposes, providing the necessary operational flexibility for day-to-day needs and unforeseen strategic expenditures.

Market Opportunity: Tapping into India’s Evolving Hygiene Landscape

The disposable hygiene products market in India is on an undeniable upward trajectory, driven by several macro-economic and demographic tailwinds. India’s vast population, a growing middle class with increasing disposable incomes, heightened awareness about health and hygiene, and changing consumer lifestyles are all contributing to robust demand. The market spans critical segments: baby care (diapers, wipes), feminine hygiene (sanitary napkins), and adult incontinence (adult diapers, underpads). Each of these segments is witnessing significant growth, albeit at different paces.

In baby care, increasing urbanization and the rise of nuclear families have led to a greater adoption of disposable diapers and wipes for convenience and hygiene. The feminine hygiene segment benefits from ongoing initiatives to promote menstrual health and product accessibility. The adult incontinence market, while nascent, is poised for explosive growth due to India’s aging population and increased healthcare awareness. Swara Baby Products, with its diversified portfolio, is uniquely positioned to capitalize on these trends across the spectrum.

The company’s strength lies in its dual strategy: being a reliable contract manufacturer for established brands and developing its own products. This approach allows it to mitigate risks by not being solely dependent on its own brand’s market fluctuations while also capturing value through its proprietary offerings. The competitive landscape includes both large multinational corporations with their own manufacturing facilities and smaller, specialized local players. However, Swara Baby Products’ scale, operational efficiency, and deep understanding of the Indian market give it a distinct advantage, particularly in securing and retaining large contract manufacturing orders.

What’s Next: A Future of Expanded Capacity and Market Leadership

With the fresh capital from the IPO, Swara Baby Products is poised to enter its next phase of accelerated growth. The immediate priority will be the swift establishment and operationalization of its new manufacturing facility in Madhya Pradesh. This expansion is not merely about increasing output, but also about integrating advanced manufacturing technologies and sustainable practices to enhance efficiency and reduce environmental footprint. The company will likely focus on optimizing its supply chain, further reducing costs, and improving its time-to-market for new products, whether for its own brands or for its contract manufacturing partners.

Further strategic acquisitions, especially those that bring complementary product lines or advanced manufacturing capabilities, are firmly on the horizon, signaling a proactive approach to consolidating its market leadership. The IPO will also significantly enhance Swara Baby Products’ brand visibility and credibility, not just among consumers but also within the B2B segment, potentially attracting new contract manufacturing clients. As a publicly listed entity, the company will face increased scrutiny and expectations for consistent performance, but with its strong financial track record and clear growth strategy, Swara Baby Products appears well-equipped to navigate these challenges and cement its position as a dominant force in India’s disposable hygiene sector.